Anna M. Wu, Ph.D, is Professor and Chair, Department of Immunology and Theranostics at the Beckman Research Institute of City of Hope and the Fouad Kandeel Chair in Diabetes and Metabolism Research, Arthur Riggs Diabetes and Metabolism Research Institute. She holds joint appointment in the Departmentof Radiation Oncology and serves as Co-Director, Center for Theranostic Studies at the City of Hope. She previously served as Professor and Vice Chair, Department of Molecular and Medical Pharmacology, Geffen School of Medicine at UCLA, where she was also Director, Cancer Molecular Imaging Program, Jonsson Comprehensive Cancer Center and Co-Associate Director, Crump Institute for Molecular Imaging. Dr. Wu is a Fellow and Past President of the World Molecular Imaging Society, and Fellow of the Society of Nuclear Medicine and Molecular Imaging. Dr. Wu’s research interests include engineered antibodies and proteins for targeting, imaging, and therapeutic applications in cancer and immunology, including the use of SPECT, PET, optical and multimodality and theranostic approaches. Dr. Wu is the Co-Founder of ImaginAb, Inc., which develops and commercializes radiolabeled antibodies for clinical use. Dr. Wu received her A.B. degree in Biochemical Sciences from Harvard University, and a Ph.D. from Yale University in Molecular Biophysics and Biochemistry. Postdoctoral studies were conducted at Yale University and at the University of California, San Francisco.
Anna M. Wu, Ph.D, FSNMMI
